retatrutide mechanism triple agonist glp-1 gip glucagon receptor LY3437943, a novel glucagon, GIP, and for glycemic control and weight loss: From discovery to clinical proof of concept Retatrutide: The triple agonist powering

Lunch and dinner: Target 2535g protein at each meal, prioritizing protein-rich foods first when appetite is limited

Schedule: Weeks 1-4: 2mg weekly Week 5+: 4mg weekly (maintenance) This protocol reaches maintenance by week 5 and provides clinically meaningful weight loss with the mildest side effect profile

Best Practice: Eat a light, balanced meal (think: lean protein + low-starch veggies) Avoid high-fat, high-sugar meals beforehand 3

[DOI] [PubMed] [Google Scholar] 21.Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ

GLP-1 medications activate receptors in brain reward circuits that overlap with addiction pathways

Using the same injection spot repeatedly: Injecting into the identical location week after week leads to lipohypertrophy and tissue damage